(Date:5/15/2008)...lts obtained with a newly cleared device to identi...terest that are associated with ...ass., May 15 /- InfraReDx, Inc. today... Royal Oak, Mich., have,successfully used its Lipi...rgoing a cardiac catheterization. This is the firs...
(Date:5/15/2008)...S, Fla., May 15 /- Tigris Pharmaceuti...erative Research and,Development Agreement (CRADA)...borate on clinical and preclinical development of ...lopment. AFP-464 is converted to,metabolites which...on and,apoptosis., This is part of a four-year CR...
(Date:5/15/2008)...xpected soon after CEA Trial data reports in third... FRANCISCO, May 15 /- VIA P...logy company focused on the development of,compoun...nounced today that,it has completed patient enroll...he ACS study is one of three Phase 2 trials invest...
(Date:5/14/2008)...tralia, May 14 /- Progen,Ph...y announced that the,Company has resumed patient e...ts recently acquired polyamine analogue, PG-11047 ...ncer., Progen has commenced development of PG-110...olyamine program - following its acquisition of,Ce...
Breaking Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2Guardian of genome predicts treatment outcomes for childhood cancer 5495 1Heart failure patients benefit from nurse led intervention 5493 1Heart failure patients benefit from nurse led intervention 5493 2Shigetada Nakanishi receives 24500 000 Gruber Neuroscience Prize 1103 1Shigetada Nakanishi receives 24500 000 Gruber Neuroscience Prize 1103 2American Chemical Societys Weekly PressPac Oct 31 2007 1101 1American Chemical Societys Weekly PressPac Oct 31 2007 1101 2American Chemical Societys Weekly PressPac Oct 31 2007 1101 3American Chemical Societys Weekly PressPac Oct 31 2007 1101 4American Chemical Societys Weekly PressPac Oct 31 2007 1101 5American Chemical Societys Weekly PressPac Oct 31 2007 1101 6American Chemical Societys Weekly PressPac Oct 31 2007 1101 7American Chemical Societys Weekly PressPac Oct 31 2007 1101 8(Date:5/16/2008)...ld help docs determine who would benefit most from...DAY, May 16 (HealthDay News) -- A panel of 15 gene...ge non-small cell lung cancer will experience a re...motherapy, a new study shows. , By extension, ...nts with less aggressive forms of the cancer who w...
(Date:5/16/2008)... LONDON, May 16 /PRNewswire/ -- Huntsworth plc (LS...ic relations and healthcare communications,group h...ement report with,respect to the Group,s performan...rch 31, 2008)., The statement follows below., ...th plc, Interim Management S...
(Date:5/16/2008)...ur and five year-old Chinese students learn the le... of the Sichuan earthquake, NANJING, China, May 1...ing Sichuan earthquake, even the youngest members ...ion and relief efforts. All around the,country, sc... campaigns.,Led by the school,s principal, Ms. Zha...
(Date:5/16/2008)... Research Funding Per Death Drops More in 2007, W... lung cancer causes,one in three cancer deaths, th...an 5% of its $4.8 billion budget in lung cancer re...sued by Lung Cancer Alliance (LCA) today., The tw...esearch,programs -- Centers for Disease Control an...
Breaking Medicine News(10 mins):Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2Health News:Lung Cancer Still Lowest in Federal Funding 2...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: